Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

Lei, Peng, Ayton, Scott, Finkelstein, David I, Spoerri, Loredana, Ciccotosto, Giuseppe D, Wright, David K, Wong, Bruce X W, Adlard, Paul A +9 more·2012·Nature Medicine

DOI 10.1038/nm.2613

Cited by (596)

Items 101–200 of 596

Role and mechanism of ferroptosis in neurological diseases
Mengmeng Ou, Ying Jiang, Yingying Ji, Qin Zhou, Zhi‐qiang Du, Haohao Zhu, Zhenhe Zhou · 2022 · Molecular Metabolism
The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin
Douglas G. Peters, James R. Connor, Mark D. Meadowcroft · 2015 · Neurobiology of Disease
Motor and cognitive deficits in aged tau knockout mice in two background strains
Lei, Peng, Ayton, Scott, Moon, Steve, Zhang, Qihao, Volitakis, Irene, Finkelstein, David I, Bush, Ashley I · 2014 · Molecular Neurodegeneration
Mammalian iron transporters: Families SLC11 and SLC40
Nicolás Montalbetti, Alexandre Simonin, Gergely Kovács, Matthias A. Hediger · 2013 · Molecular Aspects of Medicine
Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective
Paul J. Derry, Muralidhar L. Hegde, George R. Jackson, Rakez Kayed, James M. Tour, Ah-Lim Tsai, Thomas A. Kent · 2019 · Progress in Neurobiology
An anemia of Alzheimer's disease
Noel Garry Faux, Alan Rembach, James S. Wiley, Kathryn A. Ellis, David J. Ames, Christopher James Fowler, Ralph Nigel Martins, Kelly Kathleen Pertile, Rebecca L. Rumble, Brett O. Trounson et al. · 2014 · Molecular Psychiatry
Iron overload: Effects on cellular biochemistry
Leilismara Sousa Nogueira, Marina Mendes Oliveira, Marco T. Pessoa, Leandro Augusto Barbosa · 2019 · Clinica Chimica Acta
Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies
Kontaxi, Christiana, Piccardo, Pedro, Gill, Andrew C. · 2017 · Frontiers in Molecular Biosciences
Tau reduction prevents disease in a mouse model of <scp>D</scp> ravet syndrome
Gheyara, Ania L., Ponnusamy, Ravikumar, Djukic, Biljana, Craft, Ryan J., Ho, Kaitlyn, Guo, Weikun, Finucane, Mariel M., Sanchez, Pascal E., Mucke, Lennart · 2014 · Annals of Neurology
Loss of MAP Function Leads to Hippocampal Synapse Loss and Deficits in the Morris Water Maze with Aging
Qiu‐Lan Ma, Xiaohong Zuo, Fusheng Yang, Oliver J. Ubeda, Dana J. Gant, Mher Alaverdyan, Nicolae Kiosea, Sean Nazari, Ping Ping Chen, Fatiha Nothias et al. · 2014 · Journal of Neuroscience
Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice
Pavle Matak, Andrija Matak, Sarah M. Moustafa, Dipendra K. Aryal, Eric J. Benner, William C. Wetsel, Nancy C. Andrews · 2016 · Proceedings of the National Academy of Sciences
Iron accumulation, glutathione depletion, and lipid peroxidation must occur simultaneously during ferroptosis and are mutually amplifying events
Robert L. Bertrand · 2017 · Medical Hypotheses
Parkinson's Disease Iron Deposition Caused by Nitric Oxide-Induced Loss of β-Amyloid Precursor Protein
Scott Ayton, Peng Lei, Dominic James Hare, James A. Duce, Jessica L. George, Paul Anthony Adlard, Catriona McLean, Jack T. Rogers, Robert A. Cherny, David Isaac Finkelstein et al. · 2015 · Journal of Neuroscience
Therapeutic strategies for tau mediated neurodegeneration
Yasumasa Yoshiyama, Virginia M.‐Y. Lee, John Q. Trojanowski · 2012 · Journal of Neurology Neurosurgery & Psychiatry
Biometals and Their Therapeutic Implications in Alzheimer's Disease
Scott Ayton, Peng Lei, Ashley Ian Bush · 2014 · Neurotherapeutics
Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders
Jing Li, Bowen Jia, Ying Cheng, Yiting Song, Qianqian Li, Chengliang Luo · 2022 · Oxidative Medicine and Cellular Longevity
Lessons from Tau-Deficient Mice
Yazi Diana Ke, Alexandra K. Suchowerska, Julia van der Hoven, Dineeka M. De Silva, Christopher W. Wu, Janet van Eersel, Arne Ittner, Lars Matthias Ittner · 2012 · International Journal of Alzheimer s Disease
Iron as a therapeutic target for Parkinson's disease
Caroline Moreau, James A. Duce, Olivier Rascol, Jean-Christophe Devedjian, Daniela Berg, David Trevor Dexter, Z. Ioav Cabantchik, Ashley Ian Bush, David Devos, the FAIRPARK‐II study group · 2018 · Movement Disorders
Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
The FAIRPARK-II and FAIRALS-II studygroups, David Devos, Zvi Ioav Cabantchik, Caroline Moreau, Véronique Danel-Brunaud, Laura Mahoney‐Sanchez, Hind Bouchaoui, Flore Gouel, Anne‐Sophie Rolland, James A. Duce et al. · 2020 · Journal of Neural Transmission
Iron dysregulation in Huntington's disease
Michelle Müller, Blair R. Leavitt · 2014 · Journal of Neurochemistry
Microglia in Alzheimer’s Disease in the Context of Tau Pathology
Juan Ramón Perea, Marta Bolós, Jesús Ávila · 2020 · Biomolecules
Tau: The Center of a Signaling Nexus in Alzheimer's Disease
Shahzad S. Khan, George S. Bloom · 2016 · Frontiers in Neuroscience
Age-Dependent Effects of A53T Alpha-Synuclein on Behavior and Dopaminergic Function
Adam W. Oaks, Maya Frankfurt, David Isaac Finkelstein, Anita Sidhu · 2013 · PLoS ONE
Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice
Meaghan Morris, Patricia Hamto, Anthony Adame, Nino Devidze, Eliezer Masliah, Lennart Mucke · 2013 · Neurobiology of Aging
Mitochondrial iron metabolism and neurodegenerative diseases
Ruiying Cheng, Varun V. Dhorajia, Jonghan Kim, Yuho Kim · 2021 · NeuroToxicology
Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease
Bruno Bulic, Marcus Pickhardt, Eckhard Mandelkow� · 2013 · Journal of Medicinal Chemistry
An iron–dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta
Dominic James Hare, Peng Lei, Scott Ayton, Blaine Russell Roberts, Rudolf Grimm, Jessica L. George, David Bishop, Alison D. Beavis, Sarah J. Donovan, Gawain McColl et al. · 2014 · Chemical Science
Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis
Botond Penke, Mária Szűcs, Ferenc Bogár · 2020 · Molecules
CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
Changqin Liu, Brenna Cholerton, Min Yan Shi, Carmen Ginghină, Kevin C. Cain, Peggy Auinger, Jing Zhang · 2015 · Parkinsonism & Related Disorders
Progressive supranuclear palsy: Advances in diagnosis and management
David G. Coughlin, Irene Litvan · 2020 · Parkinsonism & Related Disorders
Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation
Eun‐Jae Lee, Hyejin Lee, Tzyy‐Nan Huang, Changuk Chung, Wangyong Shin, Kyungdeok Kim, Jae‐Young Koh, Yi‐Ping Hsueh, Eunjoon Kim · 2015 · Nature Communications
Tau in the Pathophysiology of Parkinson’s Disease
Lina Pan, Lanxia Meng, Mingyang He, Zhentao Zhang · 2021 · Journal of Molecular Neuroscience
Allosteric Heat Shock Protein 70 Inhibitors Rapidly Rescue Synaptic Plasticity Deficits by Reducing Aberrant Tau
Jose Francisco Abisambra, Umesh K. Jinwal, Yoshinari Miyata, Justin T. Rogers, Laura J. Blair, Xiaokai Li, Sandlin P. Seguin, Li Wang, Ying Lan Jin, Justin A. Bacon et al. · 2013 · Biological Psychiatry
Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease
Md. Tanvir Kabir, Md. Sahab Uddin, Sonia Zaman, Yesmin Begum, Ghulam Md Ashraf, May Nasser Bin-Jumah, SIMONA GABRIELA BUNGAU, Shaker A. Mousa, Mohamed M. Abdel‐Daim · 2020 · Molecular Neurobiology
Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo
DeVos, Sarah L, Corjuc, Bianca T, Commins, Caitlin, Dujardin, Simon, Bannon, Riley N, Corjuc, Diana, Moore, Benjamin D, Bennett, Rachel E, Jorfi, Mehdi, Gonzales, Jose A et al. · 2018 · Brain
NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport
Yan Jouroukhin, Regina Ostritsky, Yaniv Assaf, Galit Pelled, Eliezer Giladi, Illana Gozes · 2013 · Neurobiology of Disease
Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
Shalini S. Rao, Paul Anthony Adlard · 2018 · Frontiers in Molecular Neuroscience
Quantitative Susceptibility Mapping: Basic Methods and Clinical Applications
Taisuke Harada, Kohsuke Kudo, Noriyuki Fujima, Masato Yoshikawa, Yohei Ikebe, Ryota Sato, Toru Shirai, Yoshitaka Bito, Ikuko Uwano, Mari Miyata · 2022 · Radiographics
Tau physiology and pathomechanisms in frontotemporal lobar degeneration
Bodea, Liviu‐Gabriel, Eckert, Anne, Ittner, Lars Matthias, Piguet, Olivier, Götz, Jürgen · 2016 · Journal of Neurochemistry
Iron and Neurodegeneration: Is Ferritinophagy the Link?
Giorgio Biasiotto, Diego Di Lorenzo, Silvana Archetti, Isabella Zanella · 2015 · Molecular Neurobiology
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Yao Xiang, Xiaohua Song, Dingxin Long · 2024 · Archives of Toxicology
Impaired iron status in aging research
Xu, Jinze, Jia, Zhenhua, Knutson, Mitchell D., Leeuwenburgh, Christiaan · 2012 · International Journal of Molecular Sciences
Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease?
Zhong‐Ming Qian, Ya Ke · 2014 · Frontiers in Aging Neuroscience
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
David Isaac Finkelstein, Jessica L. Billings, Paul Anthony Adlard, Scott Ayton, Amelia Sedjahtera, Colin Louis Masters, Simon Wilkins, David M. Shackleford, Susan A. Charman, Wojciech Bal et al. · 2017 · Acta Neuropathologica Communications
Advances in the Chemical Biology of Desferrioxamine B
Rachel Codd, Tomas Richardson‐Sanchez, Thomas J. Telfer, Michael P. Gotsbacher · 2017 · ACS Chemical Biology
How Can Insulin Resistance Cause Alzheimer’s Disease?
Ji Hye Yoon, Joohyun Hwang, Sung Un Son, Junhyuk Choi, Seung-Won You, Hyun‐Woo Park, Seung-Yun Cha, Sungho Maeng · 2023 · International Journal of Molecular Sciences
Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
Xiaoyan Zeng, Hedi An, Fei Yu, Kai Wang, Lanlan Zheng, Wei Jie Zhou, Yiwen Bao, Jie Yang, Nan Shen, Dongya Huang · 2021 · Neurochemical Research
Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease
Kai Chen, Xiaobing Jiang, Moxin Wu, Xianming Cao, Wendai Bao, Ling‐Qiang Zhu · 2021 · Frontiers in Cell and Developmental Biology
Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles
Akram Bardestani, Shiva Ebrahimpour, Ali Esmaeili, Abolghasem Esmaeili · 2021 · Journal of Nanobiotechnology
Iron homeostasis imbalance and ferroptosis in brain diseases
Haining Long, Wangshu Zhu, Liming Wei, Jungong Zhao · 2023 · MedComm
Glial Cell Ceruloplasmin and Hepcidin Differentially Regulate Iron Efflux from Brain Microvascular Endothelial Cells
Ryan C. McCarthy, Daniel J. Kosman · 2014 · PLoS ONE
Tau Reduction Diminishes Spatial Learning and Memory Deficits after Mild Repetitive Traumatic Brain Injury in Mice
Cheng, Jason S., Craft, Ryan, Yu, Gui-Qiu, Ho, Kaitlyn, Wang, Xin, Mohan, Geetha, Mangnitsky, Sergey, Ponnusamy, Ravikumar, Mucke, Lennart · 2014 · PLoS ONE
Is early-life iron exposure critical in neurodegeneration?
Dominic James Hare, Manish Arora, Nicole L. Jenkins, David Isaac Finkelstein, Philip Doble, Ashley Ian Bush · 2015 · Nature Reviews Neurology
Treating Alzheimer's disease by targeting iron
Sara Nikseresht, Ashley Ian Bush, Scott Ayton · 2019 · British Journal of Pharmacology
Slow Excitotoxicity in Alzheimer's Disease
Wei-Yi Ong, Kazuhiro Tanaka, Gavin Stewart Dawe, Lars Matthias Ittner, A. A. Farooqui · 2013 · Journal of Alzheimer s Disease
Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia
Hans Zempel, Eva‐Maria Mandelkow · 2015 · Molecular Neurodegeneration
Iron metabolism: current facts and future decisions
Leida Tandara, Ilza Salamunić · 2012 · Biochemia Medica
Iron–sulfur cluster biosynthesis and trafficking – impact on human disease conditions
Christine Wachnowsky, Insiya Fidai, James Allan Cowan · 2017 · Metallomics
Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer’s and Parkinson’s disease models
Feng, Si-Tong, Wang, Zhen-Zhen, Yuan, Yu-He, Sun, Hong-Mei, Chen, Nai-Hong, Zhang, Yi · 2019 · Pharmacological Research
Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration
Lorène Penazzi, Lidia Bakota, Roland Brandt · 2015 · International review of cytology
Role of iron in brain development, aging, and neurodegenerative diseases
Qiqi Gao, Yiyang Zhou, Yu Chen, Wei Hu, Wenwen Jin, Chunting Zhou, Hao Yuan, Jianshun Li, Zhenlang Lin, Wei Lin · 2025 · Annals of Medicine
Type‐1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's disease
Main, Bevan S., Zhang, Moses, Brody, Kate M., Ayton, Scott, Frugier, Tony, Steer, David, Finkelstein, David, Crack, Peter J., Taylor, Juliet M. · 2016 · Glia
New Features about Tau Function and Dysfunction
Miguel Medina, Félix Hernández, Jesús Ávila · 2016 · Biomolecules
Much More Than a Cytoskeletal Protein: Physiological and Pathological Functions of the Non-microtubule Binding Region of Tau
Roland Brandt, Nataliya I. Trushina, Lidia Bakota · 2020 · Frontiers in Neurology
Expression of Iron Transporters and Pathological Hallmarks of Parkinson’s and Alzheimer’s Diseases in the Brain of Young, Adult, and Aged Rats
Lina Lü, Zhong‐Ming Qian, Ka-Chun Wu, Wing‐Ho Yung, Ya Ke · 2016 · Molecular Neurobiology
Targeting tau: clinical trials and novel therapeutic approaches
VandeVrede, Lawren, Boxer, Adam L., Polydoro, Manuela · 2020 · Neuroscience Letters
Ferrosenescence: The iron age of neurodegeneration?
Adonis Sfera, Kelsey Bullock, Amy I Price, Luzmin Inderias, Carolina Pereira Osorio · 2017 · Mechanisms of Ageing and Development
Small-Molecule Activator of UNC-51-Like Kinase 1 (ULK1) That Induces Cytoprotective Autophagy for Parkinson’s Disease Treatment
Liang Ouyang, Lan Zhang, Shouyue Zhang, Dahong Yao, Yuqian Zhao, Guan Wang, Leilei Fu, Peng Lei, Bo Liu · 2018 · Journal of Medicinal Chemistry
Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse
Peng Lei, Scott Ayton, Ambili Thoppuvalappil Appukuttan, Irene Volitakis, Paul Anthony Adlard, David Isaac Finkelstein, Ashley Ian Bush · 2015 · Neurobiology of Disease
Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease
Xiaotian Huang, Zhong‐Ming Qian, Xuan Meng He, Qi Gong, Ka-Chun Wu, Lirong Jiang, Lina Lü, Zhou-Jing Zhu, Haiyan Zhang, Wing‐Ho Yung et al. · 2013 · Neurobiology of Aging
Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
The Parkinson Study Group DATATOP Investigators, Jing Zhang, Hayley A. Mattison, Changqin Liu, Carmen Ginghină, Peggy Auinger, Michael McDermott, Tessandra Stewart, Un Jung Kang, Kevin C. Cain et al. · 2013 · Acta Neuropathologica
Lithium suppression of tau induces brain iron accumulation and neurodegeneration
Peng Lei, Scott Ayton, Ambili Thoppuvalappil Appukuttan, Steve Moon, James A. Duce, Irene Volitakis, Robert A. Cherny, Stephen James Wood, Mark A. Greenough, Gregor Emanuel Berger et al. · 2016 · Molecular Psychiatry
Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress.
2012 · Europe PMC (PubMed Central)
Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways
Marzia Perluigi A, Eugenio Barone, Fabio Di Domenico, David Allan Butterfield · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
What Renders TAU Toxic
Jürgen Götz, Di Xia, Gerhard Leinenga, Yee Lian Chew, Hannah Nicholas · 2013 · Frontiers in Neurology
Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery
Wu, Xiaolei, Yang, Zhangzhong, Zou, Jinjun, Gao, Huile, Shao, Zhenhua, Li, Chuanzhou, Lei, Peng · 2025 · Signal Transduction and Targeted Therapy
The calcium–iron connection in ferroptosis-mediated neuronal death
Silvia Gleitze, Andrea Cristina Paula-Lima, Marco Tulio Núñez, Cecilia Hidalgo · 2021 · Free Radical Biology and Medicine
Higher iron in the red nucleus marks Parkinson's dyskinesia
Lewis, Mechelle M., Du, Guangwei, Kidacki, Michal, Patel, Nisargkumar, Shaffer, Michele L., Mailman, Richard B., Huang, Xuemei · 2013 · Neurobiology of Aging
Exposure of metal toxicity in Alzheimer’s disease: An extensive review
Islam, Fahadul, Shohag, Sheikh, Akhter, Shomaya, Islam, Md. Rezaul, Sultana, Sharifa, Mitra, Saikat, Chandran, Deepak, Khandaker, Mayeen Uddin, Ashraf, Ghulam Md, Idris, Abubakr M. et al. · 2022 · Frontiers in Pharmacology
Iron Exposure and the Cellular Mechanisms Linked to Neuron Degeneration in Adult Mice
Lin-Bo Li, Rui Chai, Shuai Zhang, Shuangfeng Xu, Yanhui Zhang, Hailong Li, Yonggang Fan, Chuang Guo · 2019 · Cells
Tau at the interface between neurodegeneration and neuroinflammation
Didonna, Alessandro · 2020 · Genes & Immunity
Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice
David Isaac Finkelstein, Dominic James Hare, Jessica L. Billings, Amelia Sedjahtera, Milawaty Nurjono, Elisa Arthofer, Sonia George, Janetta Gladys Culvenor, Ashley Ian Bush, Paul Anthony Adlard · 2015 · ACS Chemical Neuroscience
The Complex Role of Apolipoprotein E in Alzheimer’s Disease: an Overview and Update
Laura Mahoney‐Sanchez, Abdel Ali Belaidi, Ashley Ian Bush, Scott Ayton · 2016 · Journal of Molecular Neuroscience
Ferroptosis and endoplasmic reticulum stress in ischemic stroke
Yina Li, Mingyang Li, Shi Feng, Qingxue Xu, Xu Dong Zhang, Xiaoxing Xiong, Lijuan Gu · 2023 · Neural Regeneration Research
Nitric Oxide, Iron and Neurodegeneration
Chao Liu, Mui Cheng Liang, Tuck Wah Soong · 2019 · Frontiers in Neuroscience
Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson’s disease
Scott Ayton, Peng Lei, Paul Anthony Adlard, Irene Volitakis, Robert A. Cherny, Ashley Ian Bush, David Isaac Finkelstein · 2014 · Molecular Neurodegeneration
Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
Brian Stephen Appleby, Jeffrey L. Cummings · 2013 · Current Topics in Medicinal Chemistry
Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease
James A. Duce, Bruce X. W. Wong, Hannah Durham, Jean-Christophe Devedjian, David P. Smith, David Devos · 2017 · Molecular Neurodegeneration
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
Hare, Dominic J., Adlard, Paul A., Doble, Philip A., Finkelstein, David I. · 2013 · Metallomics
A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies
Jie Zheng, Na Tian, Fei Liu, Yidian Zhang, Jingfen Su, Yang Gao, Mingmin Deng, Linyu Wei, Jingwang Ye, Honglian Li et al. · 2021 · Signal Transduction and Targeted Therapy
NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy
Shmma Quraishe, C M Cowan, Amritpal K. Mudher · 2013 · Molecular Psychiatry
Aging is associated with increased brain iron through cortex-derived hepcidin expression
Tatsuya Sato, Jason Solomon Shapiro, Hsiang-Chun Chang, Richard A. Miller, Hossein Ardehali · 2021 · eLife
Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson’s disease
Cynthia Sandor, Paul Robertson, Charmaine Lang, Andreas Heger, Heather Booth, Jane Vowles, Lorna Witty, Rory J. Bowden, Michele Hu, Sally A. Cowley et al. · 2016 · Human Molecular Genetics
Iron: Effect of Overload and Deficiency
Robert C. Hider, Xiaole Kong · 2013 · Metal ions in life sciences
The Dual Role of Hepcidin in Brain Iron Load and Inflammation
Driton Vela · 2018 · Frontiers in Neuroscience
Ferroptosis: A potential therapeutic target for neurodegenerative diseases
D. Vitalakumar, Ankita Sharma, Swaran J.S. Flora · 2021 · Journal of Biochemical and Molecular Toxicology
P-tau217 correlates with neurodegeneration in Alzheimer’s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy
Denghong Zhang, Wei Zhang, Ming Chen, Xuheng Gao, Huilong Yuan, Xiaojie Lin, Xinru Mao, Chunping Wang, Xiaoyi Guo, Ying Du et al. · 2024 · Neuron
Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species
Julia E. Gerson, Diana Laura Castillo‐Carranza, Rakez Kayed · 2014 · ACS Chemical Neuroscience
Seizure resistance without parkinsonism in aged mice after tau reduction
Li, Zhiyong, Hall, Alicia M., Kelinske, Mark, Roberson, Erik D. · 2014 · Neurobiology of Aging
Iron and Neurodegeneration: From Cellular Homeostasis to Disease
Liliana S. Batista-Nascimento, Catarina Pimentel, Regina Menezes, Claudina Rodrigues‐Pousada · 2012 · Oxidative Medicine and Cellular Longevity